Skip to main content

Advertisement

SpringerLink
Log in

Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

We assessed the impact of prophylaxis with the oral itraconazole solution and amphotericin B solution on fungal colonization and infection in a randomized study among patients with hematological malignancies and neutropenia. Infecting and colonizing Candida strains of patients suffering from candidiasis were genotyped by random amplification of polymorphic DNA (RAPD) analysis. A total of 106 patients were evaluated in this study: 52 patients in the itraconazole and 54 in the amphotericin B arm. During neutropenia fungal colonization in the oropharynx occurred in 11 (19.6%) and 24 (40.6%) and in the rectum in 11 (19.6%) and 23 (38.9%) courses in the itraconazole and amphotericin B groups (P<0.05), respectively. Candida albicans was the most prevalent species in both study groups. Mixed fungal colonization with Candida krusei and Candida glabrata was increased in the amphotericin B group, yet without clinical importance since infections were due to C. albicans. The occurrence of invasive candidiasis was significantly increased in multicolonized compared to monocolonized patients. In the amphotericin B group 20 and in the itraconazole group 2 neutropenic patients showed multicolonization with Candida spp. (P<0.05). Overall fungal infections were 3.8% in the itraconazole and 14.8% in the amphotericin B group (P<0.05). RAPD typing showed oropharynx strains involved in superficial infections in four of five patients. In all four patients with deep fungal infections, it appears that the colonizing rectum strains were identical to infecting strains of Candida spp. Itraconazole solution significantly reduced Candida colonization and infection compared to amphotericin B solution. Most patients remained infected with the colonized strains for the entire study period, irrespective of antifungal prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Denning D, Legrand P, Hostetler JS, Pappas P, Kauffman CA, Dewsnup DH, Galgiani JN, Graybill JR, Sugar AM, Cantanzaro A (1994) NIAID Mycosis Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 97:135–144

    Google Scholar 

  2. Denning DW (1991) Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. J Antimicrob Chemother 28 [Suppl B]:1–16

  3. Bodey GP, Bueltmann B, Duguid W, Gibbs D, Hanak H, Hotchi M, Mall G, Martino P, Meunier F, Milliken S (1992) Fungal infections in cancer patients: an international autopsy study. Eur J Clin Microbiol Infect Dis 11:99–109

    CAS  PubMed  Google Scholar 

  4. Kullberg B, Lashof O (2002) Epidemiology of opportunistic invasive mycoses. Eur J Med Res 7:183–191

    CAS  PubMed  Google Scholar 

  5. Pfaffenbach B, Donhuijsen K, Pahnke J, Bug R, Adamek RJ, Wege M, Ricken D (1994) Systemic fungal infections in hematologic neoplasms. An autopsy study of 1053 patients. Med Klin 89:299–304

    CAS  PubMed  Google Scholar 

  6. Anaissie E, Bodey GP (1989) Nosocomial fungal infections. Old problems and new challenges. Infect Dis Clin North Am 3:867–882

    CAS  PubMed  Google Scholar 

  7. Inoue S, Wirman JA, Alexander JW, Trocki O, Cardell RR (1988) Candida albicans translocation across the gut mucosa following burn injury. J Surg Res 44:479–492

    CAS  PubMed  Google Scholar 

  8. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H, Shadduck RK, Shea TC, Stiff P, Friedman DJ, Powderly WG, Silber J, Horowitz H, Lichtin A (1992) A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 326:845–851

    CAS  PubMed  Google Scholar 

  9. Meunier F (1987) Prevention and mycoses in immunocompromised patients. Rev Infect Dis 9:408–416

    CAS  PubMed  Google Scholar 

  10. Winston DJ, Chandrasekar PH, Lazarus HM, Goodman JL, Silber JL, Horowitz H, Shadduck RK, Rosenfeld CS, Ho WG, Islam MZ, Buell DN (1993) Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Ann Intern Med 118:495–503

    CAS  PubMed  Google Scholar 

  11. Harousseau J, Dekker AW, Stamatoullas-Bastard A, Fassas A, Linkesch W, Gouveia J, DeBock R, Rovira M, Seifert WF, Joosen H, Peeters M, DeBeule K (2000) Itraconazole oral solution for primary prophylaxis of fungal infections in patients wit hematological malignancy and profound neutropenia: a randomized, double-blind, double placebo, multicenter trial comparing itraconazole and amphotericin B. Antimicrob Agents Chemother 44:1887–1893

    CAS  PubMed  Google Scholar 

  12. Böhme A, Just-Nübling G, Bergman L, Shah PM, Stille W, Hoelzer D (1996) Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with hematological malignancies. J Antimicrob Chemother 38:953–961

    Google Scholar 

  13. National Committee for Clinical Laboratory Standards (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. NCCLS, Villanova, PA, USA

  14. Metzgar D, van Belkum A, Field D, Haubrich R, Wills C (1998) Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens. J Clin Microbiol 36:2308-2313

    Google Scholar 

  15. Glasmacher A, Hahn C, Molitor E, Sauerbruch T, Schmidt-Wolf I, Marklein G (1999) Fungal surveillance cultures during antifungal prophylaxis with itraconazole in neutropenic patients with acute leukaemia. Mycoses 42:395–402

    Article  CAS  PubMed  Google Scholar 

  16. Vreugdenhil G, Van Dijke J, Donnelly JP, Novakova IR, Raemaekers JM, Hoogkamp-Korstanje JA, Koster M, de Bauw BE (1993) Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leuk Lymphoma 11:353–358

    CAS  PubMed  Google Scholar 

  17. Beck-Sague CM, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. The National Nosocomial Infections Surveillance System. J Infect Dis 167:1247–1251

    CAS  PubMed  Google Scholar 

  18. Nucci M, Anaissie, E (2001) Revisiting the source of candidemia: skin or gut? Clin Infect Dis 33:1959–1967

    Google Scholar 

  19. Cole G, Halawa A, Anaissie E (1996) The role of gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin Infect Dis 22 [Suppl 2]:73–88

    Google Scholar 

  20. Bjorson H, Colley R, Bower R, Duty V, Schwartz-Fulton J, Fischer J (1982) Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 92:720–727

    PubMed  Google Scholar 

  21. Marr K, Seidel K, White T, Bowden R (2000) Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after adoption of prophylactic fluconazole. J Infect Dis 181:309–316

    CAS  PubMed  Google Scholar 

  22. Lass-Flörl C, Nagl M, Speth C, Ulmer H, Dierich MP, Würzner R (2001) Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining. Antimicrob Agents Chemother 45:124–128

    Article  PubMed  Google Scholar 

  23. Menichetti F, Del Favero A, Martino P, Bucaneve G, Micozzi A, Girmenia C, Barbabietola G, Pagano L, Leoni P, Specchia G, Caiozzo A, Raimondi R, Mandelli F (1999) Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. Clin Infect Dis 28:250–255

    CAS  PubMed  Google Scholar 

  24. Glasmacher A, Hahn C, Leutner C, Molitor E, Wardelmann E, Losem C, Sauerbruch T, Marklein G, Schmidt-Wolf I (1999) Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole. Mycoses 42:443–451

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hygiene and Social Medicine, University of Innsbruck, Fritz Pregl Strasse 3/III, 6020, Innsbruck, Austria

    C. Lass-Flörl, M. Englisch & M. P. Dierich

  2. Department of Hematology and Oncology, University Hospital Innsbruck, Innsbruck, Austria

    E. Gunsilius, G. Gastl & A. Petzer

  3. Department of Pharmacology, University Hospital Innsbruck, Innsbruck, Austria

    G. Koch

  4. Department of Biostatistic, University of Innsbruck, Innsbruck, Austria

    H. Ulmer

Authors
  1. C. Lass-Flörl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Gunsilius
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Gastl
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Englisch
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Ulmer
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. P. Dierich
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Petzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Lass-Flörl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lass-Flörl, C., Gunsilius, E., Gastl, G. et al. Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Ann Hematol 82, 565–569 (2003). https://doi.org/10.1007/s00277-003-0666-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-003-0666-5

Keywords

Search

Navigation